Eris Lifesciences Ltd

ERIS

Company Profile

  • Business description

    Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast. The company works basically within India and International with the majority of revenue from India.

  • Contact

    Ramdas Road
    Plot No. 142/2, Shivarth Ambit
    Off SBR, Near Swati Bungalows
    Bodakdev
    AhmedabadGJ380054
    IND

    T: +91 7969661000

    https://www.eris.co.in

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    3,558

Stocks News & Analysis

stocks

Insignia Financial: Revised deal still attractive

The offer price is well above our fair value.
stocks

Undervalued ASX income play

Major development projects remain on schedule.
stocks

Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?

With the monetization of GenAI, here’s what we think of Alphabet’s stock

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,001.4059.900.67%
CAC 407,850.43106.021.37%
DAX 4024,240.82198.920.83%
Dow JONES (US)45,010.29507.851.14%
FTSE 1009,061.4937.680.42%
HKSE25,538.07408.041.62%
NASDAQ21,020.02127.330.61%
Nikkei 22541,171.321,396.403.51%
NZX 50 Index12,794.0639.68-0.31%
S&P 5006,358.9149.290.78%
S&P/ASX 2008,737.2060.000.69%
SSE Composite Index3,582.300.440.01%

Market Movers